Cargando…
Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia
Progressive multifocal leucoencephalopathy is a serious side effect of natalizumab, a humanized monoclonal antibody approved for the treatment of multiple sclerosis. Here, we report a case of unexpected worsening of natalizumab-related progressive multifocal leucoencephalopathy following COVID-19. A...
Autores principales: | Borrelli, S., Dachy, B., Gazagnes, M-D., Du Pasquier, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054855/ https://www.ncbi.nlm.nih.gov/pubmed/33876412 http://dx.doi.org/10.1007/s13365-021-00980-2 |
Ejemplares similares
-
1766. Osimertinib-Associated Progressive Multifocal Leucoencephalopathy
por: Gilotra, Tarvinder S, et al.
Publicado: (2019) -
MULTIFOCAL LEUCOENCEPHALOPATHY PRESENTING AS ANTIDEPRESSANT INDUCED MANIA
por: Damodaran, Saji S., et al.
Publicado: (1994) -
Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report
por: Naess, Halvor, et al.
Publicado: (2010) -
Progressive multifocal leucoencephalopathy in AIDS camouflaged with catatonia: A wolf in sheep's clothing
por: Kumar, Pradeep, et al.
Publicado: (2006) -
Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes
por: Kantorová, Ema, et al.
Publicado: (2017)